TetraLogic Pharma Prices 7.15 Mln Shares IPO At $7/Shr - Quick Facts

(RTTNews) - TetraLogic Pharmaceuticals Corp. (TLOG) has priced its initial public offering or IPO of 7.15 million shares at $7.00 per share price, before underwriting discount and offering costs. All common shares are being offered by TetraLogic. Further, the underwriters were granted a 30-day option to buy up to an additional 1.07 million shares at the same price to cover over-allotments, if any. The shares may commence trading on the NASDAQ Global Market on December 12, 2013 under the symbol "TLOG." The offering may close on December 17, 2013.

TetraLogic plans to use the net proceeds of its IPO to advance the clinical and pre-clinical development of birinapant, other development programs, working capital and general corporate purposes. Oppenheimer & Co. Inc., Guggenheim Securities, LLC and Needham & Company, LLC are acting as joint book-running managers for the offering.